SITE UNDER CONSTRUCTION

Kontaktiere uns
By Jörg Karenfort

Post: Intelligent biomarkers are set to advance the development of medications for brain disorders.

January 27, 2024

AC Immune is currently developing a vaccine for Parkinson’s disease.

Incentives for innovation in the pharmaceutical sector: Rethinking competition and public policy?
Cannabinoid lindert Symptome bei Parkinson

First-time proven, approved cannabinoid alleviates symptoms in Parkinson’s disease.
fraunhofer Logo

AI and digital technology enhance diagnosis and treatment of Parkinson’s disease.
Deutsche Zentrum für Neurodegenerative Erkrankungen (DZNE)

Intelligent biomarkers are set to advance the development of medications for brain disorders.
IQWiG: Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen

Poor data availability regarding the benefits of the Feldenkrais Method for mobility disorders.